{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:37Z","timestamp":1790975137208,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112160","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:14:35Z","timestamp":1714878875000},"page":"112160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-0295","authenticated-orcid":false,"given":"Elham","family":"Ghafouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Fadaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Amirkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-920X","authenticated-orcid":false,"given":"Mahsa","family":"Esmaeilifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnaz","family":"Rahimmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-3557","authenticated-orcid":false,"given":"Hossein","family":"Khanahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112160_b0005","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1016\/j.vaccine.2019.06.034","article-title":"CTX phage of Vibrio cholerae: genomics and applications","volume":"38","author":"Pant","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.intimp.2024.112160_b0010","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/13500872-141-8-1977","article-title":"Cholera toxin (CTX) genetic element in Vibrio cholerae O139","volume":"141","author":"Bhadra","year":"1995","journal-title":"Microbiology"},{"issue":"26","key":"10.1016\/j.intimp.2024.112160_b0015","first-page":"e00454","article-title":"Genome sequence of a pathogenic Vibrio cholerae O1 El Tor Strain Defective for the Entire Vibrio Pathogenicity Island 1, Isolated in Eastern Democratic Republic of the Congo","volume":"9","author":"Irenge Leonid","year":"2020","journal-title":"Microbiology Resource Announcements"},{"key":"10.1016\/j.intimp.2024.112160_b0020","unstructured":"C. A, Principles and practice of pediatric infectious diseases, 2017."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/erv.10.150","article-title":"Vibrio cholerae: lessons for mucosal vaccine design","volume":"10","author":"Bishop","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2024.112160_b0030","first-page":"237","article-title":"Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects","volume":"84","author":"Cryz","year":"1995","journal-title":"Dev. Biol. Stand."},{"issue":"5","key":"10.1016\/j.intimp.2024.112160_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2051013614537819","article-title":"Killed oral cholera vaccines: history, development and implementation challenges","volume":"2","author":"Lopez","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.intimp.2024.112160_b0040","unstructured":"W.H. Organization, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cholera, 2022."},{"issue":"2","key":"10.1016\/j.intimp.2024.112160_b0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00328978","article-title":"The ideal vaccine","volume":"7","author":"Ada","year":"1991","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112160_b0050","first-page":"59","article-title":"Texas Star-SR: attenuated \u201cVibrio cholerae\u201d oral vaccine candidate","volume":"53","author":"Levine","year":"1983","journal-title":"Dev. Biol. Stand."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"Chen","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112160_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19127141","article-title":"Long-term kinetics of serological antibodies against Vibrio cholerae following a clinical cholera case: a systematic review and meta-analysis","volume":"19","author":"Muzembo","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"43","key":"10.1016\/j.intimp.2024.112160_b0065","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1016\/j.vaccine.2008.05.088","article-title":"Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit","volume":"26","author":"Rhie","year":"2008","journal-title":"Vaccine"},{"issue":"suppl_3","key":"10.1016\/j.intimp.2024.112160_b0070","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/infdis\/jiy414","article-title":"Cholera: immunity and prospects in vaccine development","volume":"218","author":"Harris","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2024.112160_b0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0264-410X(93)90039-Z","article-title":"Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems","volume":"11","author":"Holmgren","year":"1993","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112160_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00251-022-01282-5","article-title":"Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection","volume":"75","author":"Oladipo","year":"2023","journal-title":"Immunogenetics"},{"issue":"8","key":"10.1016\/j.intimp.2024.112160_b0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/jfd.12036","article-title":"Cloning, expression of Vibrio alginolyticus outer membrane protein-OmpU gene and its potential application as vaccine in crimson snapper, Lutjanus erythropterus Bloch","volume":"36","author":"Cai","year":"2013","journal-title":"J. Fish Dis."},{"key":"10.1016\/j.intimp.2024.112160_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.fsi.2020.11.030","article-title":"Immunogenicity study of OmpU subunit vaccine against Vibrio mimicus in yellow catfish, Pelteobagrus fulvidraco","volume":"108","author":"Fu","year":"2021","journal-title":"Fish Shellfish Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1472-765X.2011.03062.x","article-title":"Identification and evaluation of an outer membrane protein OmpU from a pathogenic Vibrio harveyi isolate as vaccine candidate in turbot (Scophthalmus maximus)","volume":"53","author":"Wang","year":"2011","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.intimp.2024.112160_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.compbiolchem.2016.04.006","article-title":"Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches","volume":"62","author":"Nezafat","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112160_b0105","doi-asserted-by":"crossref","unstructured":"M.A. Sayeed, M.K. Bufano, P. Xu, G. Eckhoff, R.C. Charles, M.M. Alam, T. Sultana, M.R. Rashu, A. Berger, G. Gonzalez-Escobedo, A. Mandlik, T.R. Bhuiyan, D.T. Leung, R.C. LaRocque, J.B. Harris, S.B. Calderwood, F. Qadri, W.F. Vann, P. Kov\u00e1\u010d, E.T. Ryan, A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice, PLoS Negl Trop Dis 9(7) (2015) e0003881.","DOI":"10.1371\/journal.pntd.0003881"},{"issue":"2","key":"10.1016\/j.intimp.2024.112160_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152190","article-title":"Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting OmpW, TcpA and CtxB, of Vibrio cholerae","volume":"227","author":"Zareitaher","year":"2022","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2024.112160_b0115","doi-asserted-by":"crossref","first-page":"1155751","DOI":"10.3389\/fmed.2023.1155751","article-title":"Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development","volume":"10","author":"Montero","year":"2023","journal-title":"Front. Med. (lausanne)"},{"key":"10.1016\/j.intimp.2024.112160_b0120","first-page":"1","article-title":"Reverse vaccinology: basics and applications","volume":"4","author":"Kanampalliwar","year":"2013","journal-title":"J. Vaccines Vaccination"},{"issue":"5","key":"10.1016\/j.intimp.2024.112160_b0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112160_b0130","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012476","article-title":"Vaccines, reverse vaccinology, and bacterial pathogenesis","volume":"3","author":"Delany","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.112160_b0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0140","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1038\/s41598-022-14427-z","article-title":"Design of a multi-epitope vaccine candidate against Brucella melitensis","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.112160_b0145","doi-asserted-by":"crossref","first-page":"e3007","DOI":"10.1002\/jmr.3007","article-title":"An immunoinformatics and structural vaccinology study to design a multi-epitope vaccine against Staphylococcus aureus infection","volume":"36","author":"Chatterjee","year":"2023","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.intimp.2024.112160_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2023.2293256","article-title":"Design of a multi-epitope vaccine (vme-VAC\/MST-1) against cholera and vibriosis based on reverse vaccinology and immunoinformatics approaches","author":"Marques","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.intimp.2024.112160_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/ITT.S241064","article-title":"Immunoinformatics and Vaccine Development: An Overview","volume":"9","author":"Oli","year":"2020","journal-title":"Immunotargets Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.112160_b0160","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s10989-021-10278-w","article-title":"Computational design and analysis of a multi-epitope against influenza A virus","volume":"27","author":"Rostaminia","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2024.112160_b0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/vim.2014.0152","article-title":"Design and antigenic epitopes prediction of a new trial recombinant multiepitopic rotaviral vaccine: in silico analyses","volume":"28","author":"Jafarpour","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.intimp.2024.112160_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6718083","article-title":"Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus","volume":"2018","author":"Adhikari","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112160_b0175","doi-asserted-by":"crossref","unstructured":"A. Gonz\u00e1lez-Mora, J. Hern\u00e1ndez-P\u00e9rez, H.M.N. Iqbal, M. Rito-Palomares, J. Benavides, Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery, Vaccines (Basel) 8(3) (2020).","DOI":"10.3390\/vaccines8030504"},{"issue":"Pt 1","key":"10.1016\/j.intimp.2024.112160_b0180","article-title":"Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy","volume":"238","author":"Fadaie","year":"2023","journal-title":"Environ. Res."},{"issue":"4705","key":"10.1016\/j.intimp.2024.112160_b0185","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112160_b0190","first-page":"215","article-title":"Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines","volume":"251","author":"Parmley","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2024.112160_b0195","doi-asserted-by":"crossref","DOI":"10.13070\/mm.en.4.873","article-title":"Phage-display technology for the production of recombinant monoclonal antibodies","volume":"4","author":"Rajput","year":"2014","journal-title":"Materials and Methods"},{"key":"10.1016\/j.intimp.2024.112160_b0200","unstructured":"C. The UniProt, UniProt: the Universal Protein Knowledgebase in 2023, Nucleic Acids Research 51(D1) (2023) D523-D531."},{"issue":"13","key":"10.1016\/j.intimp.2024.112160_b0205","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1093\/nar\/gkg510","article-title":"MHCPred: A server for quantitative prediction of peptide-MHC binding","volume":"31","author":"Guan","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00822942-200605010-00008","article-title":"MHCPred 2.0: an updated quantitative T-cell epitope prediction server","volume":"5","author":"Guan","year":"2006","journal-title":"Appl. Bioinform."},{"issue":"10","key":"10.1016\/j.intimp.2024.112160_b0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00251-013-0720-y","article-title":"NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ","volume":"65","author":"Karosiene","year":"2013","journal-title":"Immunogenetics"},{"issue":"W1","key":"10.1016\/j.intimp.2024.112160_b0220","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.intimp.2024.112160_b0230","series-title":"Artificial Immune Systems","first-page":"197","article-title":"BcePred: Prediction of Continuous B-Cell Epitopes in Antigenic Sequences Using Physico-chemical Properties","author":"Saha","year":"2004"},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"6","key":"10.1016\/j.intimp.2024.112160_b0240","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP - a server for in silico prediction of allergens","volume":"14","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinf."},{"issue":"9","key":"10.1016\/j.intimp.2024.112160_b0245","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112160_b0250","doi-asserted-by":"crossref","unstructured":"V.S. Ayyagari, C.V. T, A.P. K, K. Srirama, Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach, J Biomol Struct Dyn 40(7) (2022) 2963-2977.","DOI":"10.1080\/07391102.2020.1850357"},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0255","doi-asserted-by":"crossref","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","article-title":"Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9","volume":"11","author":"Tarrahimofrad","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.intimp.2024.112160_b0265","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0270","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2024.112160_b0275","doi-asserted-by":"crossref","unstructured":"L. Heo, H. Park, C. Seok, GalaxyRefine: Protein structure refinement driven by side-chain repacking, Nucleic Acids Res 41(Web Server issue) (2013) W384-8.","DOI":"10.1093\/nar\/gkt458"},{"issue":"4","key":"10.1016\/j.intimp.2024.112160_b0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"Laskowski","year":"1996","journal-title":"J. Biomol NMR"},{"issue":"2","key":"10.1016\/j.intimp.2024.112160_b0285","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.intimp.2024.112160_b0290","doi-asserted-by":"crossref","unstructured":"M. Wiederstein, M.J. Sippl, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic Acids Res 35(Web Server issue) (2007) W407-10.","DOI":"10.1093\/nar\/gkm290"},{"issue":"W1","key":"10.1016\/j.intimp.2024.112160_b0295","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkv495","article-title":"GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization","volume":"43","author":"Lee","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.intimp.2024.112160_b0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2024.112160_b0305","unstructured":"C.F. Barbas, D.R. Burton, J.K. Scott, G.J. Silverman, Phage display, A Laboratory Manual (2001)."},{"issue":"2","key":"10.1016\/j.intimp.2024.112160_b0310","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3934\/microbiol.2020009","article-title":"Cholera toxin phage: structural and functional diversity between Vibrio cholerae biotypes","volume":"6","author":"Safa","year":"2020","journal-title":"AIMS Microbiol"},{"key":"10.1016\/j.intimp.2024.112160_b0315","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1016\/j.vaccine.2019.07.036","article-title":"Cholera surveillance and estimation of burden of cholera","volume":"38","author":"Ganesan","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2024.112160_b0320","doi-asserted-by":"crossref","first-page":"e00211","DOI":"10.1128\/cmr.00211-21","article-title":"Diagnosis, management, and future control of cholera","volume":"35","author":"Chowdhury","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2024.112160_b0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.copbio.2020.11.002","article-title":"Phages in vaccine design and immunity; mechanisms and mysteries","volume":"68","author":"de Vries","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112160_b0330","unstructured":"U. Tsedev, <Engineering M13 Bacteriophage Nanoplatforms for Diagnostic and Therapeutic Applications.pdf>, (2021)."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T14:02:45Z","timestamp":1735308165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":66,"alternative-id":["S1567576924006787"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112160","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112160"}}